The World Health Organisation (WHO) said that clinical trials of the drug hydroxychloroquine will resume, having been suspended pending a safety review in the search for coronavirus treatments, according to AFP.

“On the basis of the available mortality data [...] the executive group will communicate with the principal investigators in the trial about resuming the hydroxychloroquine arm,” WHO chief Tedros Adhanom Ghebreyesus told a virtual news briefing.